This report focuses on the global Companion Diagnostic Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Companion Diagnostic Technologies development in United States, Europe and China.
Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment.
Companion diagnostics is segmented on the basis of its use for indications such as oncology, cardiovascular conditions, central nervous system indications, inflammation and virology. Oncology is the highest revenue generating segment, as majority of the companion diagnostics have been developed for detection of various cancer biomarkers. The key driver for this market is an increase in research and development of targeted drugs, which require a corresponding companion diagnostic.
In 2017, the global Companion Diagnostic Technologies market size was 1960 million US$ and it is expected to reach 7510 million US$ by the end of 2025, with a CAGR of 18.2% during 2018-2025.
The key players covered in this study
Dako (Agilent Technologies)
Qiagen
Roche
Abbott Laboratories, Inc.
Ventana Medical Systems
bioMerieux
Myriad Genetics, Inc.
Resonance Health Ltd.
Leica Microsystems
Life Technologies
Market segment by Type, the product can be split into
Immunohistochemistry
Molecular Diagnostics
Market segment by Application, split into
Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Companion Diagnostic Technologies status, future forecast, growth opportunity, key market and key players.
To present the Companion Diagnostic Technologies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Companion Diagnostic Technologies are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.